glp 1 meds while breastfeeding Navigating GLP-1 and Pregnancy: Insights, Safety, and Postpartum Considerations Is semaglutide use during breastfeeding

Addition of a dipeptidyl peptidase-4 inhibitor, sitagliptin, to ongoing therapy with the glucagon-like peptide-1 receptor agonist liraglutide: A randomized controlled trial in patients with type 2 diabetes

10.1007/978-3-319-48382-5_1 13 GallwitzB

Effect of Semaglutide on Liver Enzymes and Markers of Inflammation in Subjects With Type 2 Diabetes and/or Obesity

Science 184, 868871

Njlsson R, Ristoff E, Carlsson K, Winkler A, Larsson A, Norgren S

The effects of GLP-1RAs on colorectal and other cancer risk Clinical studies have demonstrated that the use of GLP-1RAs can reduce the risk of colorectal cancer, and the protective effect appears to be positively correlated with the duration of therapy